InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 97.05M | 108.04M | 118.03M | 118.45M | 115.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 97.05M | 108.04M | 118.03M | 118.45M | 115.70M |
| Cost of Revenue | 67.27M | 69.85M | 72.68M | 68.80M | 64.44M |
| Gross Profit | 29.79M | 38.20M | 45.35M | 49.65M | 51.26M |
| SG&A Expenses | 26.80M | 28.51M | 31.36M | 31.62M | 30.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.12M | 11.88M | 9.61M | 9.84M | 8.33M |
| Total Operating Expenses | 97.29M | 110.38M | 113.81M | 110.45M | 103.11M |
| Operating Income | -235.90K | -2.34M | 4.22M | 8.00M | 12.59M |
| Income Before Tax | -16.20M | -10.37M | 1.63M | 7.87M | 13.44M |
| Income Tax Expenses | 595.30K | -3.93M | -3.37M | -746.70K | 250.60K |
| Earnings from Continuing Operations | -16.79 | -6.44 | 5.00 | 8.61 | 13.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 429.80K | 1.33M | 983.80K | 714.90K | 265.70K |
| Net Income | -16.36M | -5.11M | 5.99M | 9.33M | 13.45M |
| EBIT | -235.90K | -2.34M | 4.22M | 8.00M | 12.59M |
| EBITDA | 2.57M | -31.60K | 6.83M | 10.42M | 14.85M |
| EPS Basic | -0.37 | -0.12 | 0.13 | 0.21 | 0.32 |
| Normalized Basic EPS | -0.08 | -0.09 | 0.00 | 0.09 | 0.18 |
| EPS Diluted | -0.37 | -0.12 | 0.13 | 0.20 | 0.32 |
| Normalized Diluted EPS | -0.08 | -0.09 | 0.00 | 0.08 | 0.17 |
| Average Basic Shares Outstanding | 182.29M | 182.89M | 183.43M | 178.24M | 170.63M |
| Average Diluted Shares Outstanding | 182.29M | 183.10M | 183.65M | 179.77M | 174.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |